Management tracks: Urovant, Cue

Urology company Urovant Sciences, a subsidiary of Roivant Sciences GmbH (Basel, Switzerland), hired Cornelia Haag-Molkenteller as CMO, Michael McFadden as chief commercial officer, Bryan Smith as general counsel and Christine Ocampo as SVP and chief accounting officer. Haag-Mokenteller was VP and therapeutic area head of clinical development for urology, women's health and internal medicine at Allergan plc (NYSE:AGN). McFadden was SVP of commercial at Avanir Pharmaceuticals Inc., which Otsuka Pharmaceutical Co. Ltd. (Tokyo, Japan) acquired. Smith was associate VP and senior counsel at Allergan. Ocampo was CFO at Novus Therapeutics Inc. (NASDAQ:NVUS).

Cancer and autoimmune company Cue Biopharma Inc. (NASDAQ:CUE) hired Anish Suri as CSO and SVP. He was senior director at the Janssen Immunosciences Belgium unit at Johnson & Johnson (NYSE:JNJ)...